Recap: Horizon Therapeutics Q3 Earnings

Horizon Therapeutics HZNP reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Horizon Therapeutics beat estimated earnings by 23.76%, reporting an EPS of $1.25 versus an estimate of $1.01.

Revenue was down $111.64 million from the same period last year.

Last quarter the company missed on EPS by $0.28 which was followed by a 0.06% increase in the share price the next day.

Here's a look at Horizon Therapeutics's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	1.35	1.20	1.34	1.54
EPS Actual	1.07	1.34	1.41	1.75
Revenue Estimate	936.10M	874.41M	995.87M	979.41M
Revenue Actual	876.41M	885.25M	1.01B	1.04B

To track all earnings releases for Horizon Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.